DTRTU / DTRT Health Acquisition Corp - Units (1 Ord Share Class A & 1/2 War) - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

US23344T1117 / DTRT Health Acquisition Corp. / Cowen Financial Products LLC - COWEN FINANCIAL PRODUCTS LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* DTRT Health Acquisition Corp (Name of Issuer) common stock (Title of Class of Securities) 23344T111 (CUSIP Number) December 29, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

DTRTU / DTRT Health Acquisition Corp. Unit / Saba Capital Management, L.P. - FORM SC 13G/A Passive Investment

SC 13G/A 1 formsc13ga.htm FORM SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* DTRT Health Acquisition Corp (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 23344T202 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Chec

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-40774 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specifi

US23344T1034 / DTRT Health Acquisition Corp. / BALYASNY ASSET MANAGEMENT LLC - SC 13G Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 DTRT Health Acquisition Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 23344T103 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th

US23344T1034 / DTRT Health Acquisition Corp. / CITADEL ADVISORS LLC - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 2)* DTRT HEALTH ACQUISITION CORP. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (the “Shares”) (Title of Class of Securiti

JOINT FILING AGREEMENT

Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, $0.0001 par value per share, of DTRT Health Acquisition Corp. This Joint Filing

US23344T1034 / DTRT Health Acquisition Corp. / UBS OCONNOR LLC - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* DTRT Health Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 23344T103 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to

US23344T1034 / DTRT Health Acquisition Corp. / Owl Creek Asset Management, L.P. - DTRT HEALTH ACQUISITION CORP. Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* DTRT Health Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 23344T103 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the

Certificate of Amendment to the Registrant’s Amended and Restated Certificate of Incorporation

Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DTRT HEALTH ACQUISITION CORP. DTRT Health Acquisition Corp. (the “Corporation”), a corporation organized and existing under the laws of the State of Delaware, does hereby certify as follows: 1. The name of the Corporation is DTRT Health Acquisition Corp. 2. The Corporation’s original Certificate of Inc

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 30, 2023 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or other jurisdiction of incorporation) (Com

US23344T1117 / DTRT Health Acquisition Corp. / Cowen Financial Products LLC - COWEN FINANCIAL PRODUCTS LLC Passive Investment

SC 13G/A 1 dtrta112423.htm COWEN FINANCIAL PRODUCTS LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* DTRT Health Acquisition Corp (Name of Issuer) common stock (Title of Class of Securities) 23344T111 (CUSIP Number) December 30, 2022 (Date of Event which Requires Filing of this Statement) Check the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi

US23344T1034 / DTRT Health Acquisition Corp. / Meteora Capital, LLC - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* DTRT Health Acquisition Corporation (Name of Issuer) Class A Common stock, par value $0.0001 (Title of Class of Securities) 23344T103 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to des

JOINT FILING AGREEMENT

EX-99.1 2 dtrtex9901.htm JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”) the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regula

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi

Termination of a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 5, 2023 (January 4, 2023) DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or other jurisdiction of in

US23344T1117 / DTRT Health Acquisition Corp. / Cowen Financial Products LLC - COWEN FINANCIAL PRODUCTS LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 DTRT Health Acquisition Corp (Name of Issuer) common stock (Title of Class of Securities) 23344T111 (CUSIP Number) December 13, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f

Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 2 CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 15, 2022 (December 6, 2022) DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or oth

Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 13, 2022 (December 6, 2022) DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or other jurisdiction

Amendment to the Registrant’s Amended and Restated Certificate of Incorporation.

EX-3.1 2 d432486dex31.htm EX-3.1 Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DTRT HEALTH ACQUISITION CORP. DTRT Health Acquisition Corp. (the “Corporation”), a corporation organized and existing under the by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify: 1. The name of the Corporation is DTRT He

Convertible Promissory Note dated as of December 6, 2022.

Exhibit 10.1 THIS CONVERTIBLE PROMISSORY NOTE (THIS ?NOTE?) AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE. THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFER

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 6, 2022 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or other jurisdiction of incorporation) (Com

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 2, 2022 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or other jurisdiction of incorporation) (Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 1, 2022 DTRT HEALTH ACQU

425 1 d429954d425.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 1, 2022 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or other jurisdict

Regulation FD Disclosure, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 1, 2022 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or other jurisdiction of incorporation) (Com

DTRT Health Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders

Exhibit 99.1 DTRT Health Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders Oak Brook, IL, December 1, 2022 ? DTRT Health Acquisition Corp. (?we?, ?us?, ?our?, or the ?Company?) today announced that it convened and then adjourned, without conducting any other business, its special meeting of stockholders (the ?Special Meeting?) held on December 1, 2022. The Special Meeting

DTRT Health Acquisition Corp. Announces Contributions to Trust Account in Connection with Proposed Extension

Exhibit 99.1 DTRT Health Acquisition Corp. Announces Contributions to Trust Account in Connection with Proposed Extension Oak Brook, IL, December 2, 2022 ? As previously announced on December 1, 2022, DTRT Health Acquisition Corp. (?we?, ?us?, ?our?, or the ?Company?) convened and then adjourned, without conducting any other business, its special meeting of stockholders (the ?Special Meeting?) hel

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 2, 2022 DTRT HEALTH ACQU

425 1 d421610d425.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 2, 2022 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or other jurisdict

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSU

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to DTRT Health Acquisition Corp. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi

October 27, 2022

October 27, 2022 VIA EDGAR Stacie Gorman Brigitte Lippmann Division of Corporation Finance Office of Real Estate and Construction United States Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Re: DTRT Health Acquisition Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 25, 2022 DTRT Health Acqu

425 1 d391250d425.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 25, 2022 DTRT Health Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or Other Jurisdict

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 25, 2022 DTRT Health Acqu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 25, 2022 DTRT Health Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or Other Jurisdiction of Incorporation) (Com

Convertible Promissory Note dated as October 25, 2022

EX-10.1 Exhibit 10.1 THIS CONVERTIBLE PROMISSORY NOTE (THIS “NOTE”) AND THE SECURITIES INTO WHICH IT MAY BE CONVERTED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE. THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi

Filed by DTRT Health Acquisition Corp.

Filed by DTRT Health Acquisition Corp. pursuant to Rule 425 under the Securities Act of 1933 and deemed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: DTRT Health Acquisition Corp. Commission File No.: 001-40774 Date: October 20, 2022 Consumer Direct Holdings, Inc. Announces Filing of Registration Statement on Form S-4 in Connection with Its Proposed Business Co

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 6, 2022 DTRT Health Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or Other Jurisdiction of Incorporation) (Comm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 6, 2022 DTRT Health Acqui

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 6, 2022 DTRT Health Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or Other Jurisdiction of Incorporation) (Comm

Disclaimer and Forward-Looking Statements About this Presentation This confidential investor presentation (this Presentation ) is for informational purposes only to assist interested parties in making their own evaluation with respect to a proposed b

Exhibit 99.1 Investor Presentation October 2022 Confidential E V E R Y L I F E . E V E R Y M O M E N T . E V E R Y D A Y . Disclaimer and Forward-Looking Statements About this Presentation This confidential investor presentation (this Presentation ) is for informational purposes only to assist interested parties in making their own evaluation with respect to a proposed business combination (the Bu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 28, 2022 DTRT HEALTH AC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 28, 2022 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or other jurisdiction of incorporation) (C

Form of Stockholders Agreement by and among Grizzly New Pubco, Inc. and each of the shareholders of Consumer Direct Holdings, Inc.

Exhibit 10.3 STOCKHOLDER?S AGREEMENT THIS STOCKHOLDER?S AGREEMENT (this ?Agreement?) is made as of September 28, 2022, by and between Grizzly New Pubco, Inc., a Delaware corporation (?New Pubco?), and [] (?CDH Party?). Capitalized terms not expressly defined in this Agreement shall have the meanings ascribed to them in the Merger Agreement (as defined below). RECITALS WHEREAS, reference herein is

Merger Agreement, dated as of September 28, 2022, by and among DTRT Health Acquisition Corp., Grizzly New Pubco, Inc., Grizzly Merger Sub, Inc. and Consumer Direct Holdings, Inc.

Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among DTRT HEALTH ACQUISITION CORP., GRIZZLY NEW PUBCO, INC., GRIZZLY MERGER SUB, INC., CONSUMER DIRECT HOLDINGS, INC. and THE PRE-CLOSING HOLDER REPRESENTATIVE Dated as of September 28, 2022 TABLE OF CONTENTS ARTICLE I CERTAIN DEFINITIONS SECTION 1.01 DEFINITIONS 3 SECTION 1.02 CONSTRUCTION 21 SECTION 1.03 KNOWLEDGE 22 SECTION 1.04 EQUITABLE ADJUSTM

Lockup Agreement, dated as of September 28, 2022, by and among certain shareholders of Consumer Direct Holdings, Inc., DTRT Health Sponsor LLC and DTRT Health Acquisition Corp.

Exhibit 10.5 LOCKUP AGREEMENT This LOCKUP AGREEMENT (this ?Agreement?) dated as of September 28, 2022, is entered into by and among DTRT Health Acquisition Corp., a Delaware corporation (?SPAC?), DTRT Health Sponsor LLC, a Delaware limited liability company (?Sponsor?), the shareholders of Consumer Direct Holdings, Inc., a Montana corporation (the ?Company?) identified on the signature pages heret

Sponsor Agreement, dated as of September 28, 2022, by and among DTRT Health Acquisition Corp., Grizzly New Pubco, Inc. and Consumer Direct Holdings, Inc.

Exhibit 10.2 SPONSOR AGREEMENT THIS SPONSOR AGREEMENT (this ?Agreement?), dated as of September 28, 2022, is made by and among DTRT Health Sponsor LLC, a Delaware limited liability company (?Sponsor?), DTRT Health Acquisition Corp., a Delaware corporation (?SPAC?), Grizzly New Pubco, Inc., a Delaware corporation and direct, wholly-owned subsidiary of SPAC (?Pubco?), and Consumer Direct Holdings, I

Consumer Direct Holdings, a Leading Self-Directed Personal Care Network, Announces Plans to Become a Publicly Traded Company Via Merger with DTRT Health Acquisition Corp.

Exhibit 99.1 Consumer Direct Holdings, a Leading Self-Directed Personal Care Network, Announces Plans to Become a Publicly Traded Company Via Merger with DTRT Health Acquisition Corp. The transaction provides growth capital that will enable Consumer Direct Holdings to expand its coverage footprint, allowing it to bring valuable in-home personal care to a larger demographic. The transaction implies

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 28, 2022 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or other jurisdiction of incorporation) (C

Form of Registration Rights Agreement by and among DTRT Health Acquisition Corp., DTRT Health Sponsor LLC, certain members of DTRT Health Sponsor LLC and the shareholders of Consumer Direct Holdings, Inc.

Exhibit 10.1 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of [], is made and entered into by and among Grizzly New Pubco, Inc., a Delaware corporation (the ?Company?), DTRT Health Acquisition Corp., a Delaware corporation (?SPAC?), DTRT Health Sponsor LLC, a Delaware limited liability company (the ?Sponsor?), the members of the Sponsor identified on

Equity Exchange Agreement, dated as of September 12, 2022, by and among Consumer Direct Care Washington, LLC, Consumer Direct Holdings, Inc., Grizzly New Pubco, Inc. and Home Care Workers Purpose Trust.

Exhibit 10.4 EQUITY EXCHANGE AGREEMENT THIS EQUITY EXCHANGE AGREEMENT, dated as of September 12, 2022 (this ?Agreement?), by and among Grizzly New Pubco, Inc., a Delaware corporation and direct, wholly-owned subsidiary of SPAC (?New Pubco?), and Consumer Direct Care Washington, LLC (the ?Company?), a limited liability company organized under the laws of the State of Washington, Consumer Direct Hol

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT T

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to DTRT Health Acquisition Corp. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to DTRT Health Acquisition Corp. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SE

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 001-40774 DTRT HEA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2021 ☐ T

NT 10-K 1 d345915dnt10k.htm NT 10-K SEC FILE NUMBER 001-40878 CUSIP NUMBER Units: 23344T 202 Class A: 23344T 103 Warrants: 23344T 111 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2021 ☐ Transition Report

Description of Securities.

Exhibit 4.5 DESCRIPTION OF SECURITIES The following summary of DTRT Health Acquisition Corp.?s securities is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to the Company?s amended and restated certificate of incorporation, which is incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this exhibit is a part.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSIT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Amendment No. 1 ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to DTRT Health Acquisition Corp. (Exa

DTRT HEALTH ACQUISITION CORP. Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of September 7, 2021 (As Restated) F-3 Notes to Financial Statement (As Restated) F-4

Exhibit 99.1 DTRT HEALTH ACQUISITION CORP. Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of September 7, 2021 (As Restated) F-3 Notes to Financial Statement (As Restated) F-4 Report of Independent Registered Public Accounting Firm To the Stockholders and the Board of Directors of DTRT Health Acquisition Corp. Opinion on the Financial Statement We have audited the acc

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 7, 2021 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40744 86-3336784 (State or other jurisdiction of incorporation) (

US23344T1034 / DTRT Health Acquisition Corp. / CITADEL ADVISORS LLC - DTRT HEALTH ACQUISITION CORP. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 (Amendment No. 1)* DTRT Health Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (the ?Shares?) (Title of Class of Securiti

DTRTU / DTRT Health Acquisition Corp. Unit / Saba Capital Management, L.P. - FORM SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* DTRT Health Acquisition Corp (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 23344T202 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the r

JOINT FILING AGREEMENT

Exhibit 1 JOINT FILING AGREEMENT This joint filing agreement (this ?Agreement?) is made and entered into as of this 8th day of February, 2022, by and between DTRT Health Sponsor LLC and Mark Heaney.

US23344T1034 / DTRT Health Acquisition Corp. / Heaney Mark S. - SC 13G Passive Investment

SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* Under the Securities Exchange Act of 1934 DTRT Health Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Titles of Class of Securities) 23344T 103 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropria

US23344T1034 / DTRT Health Acquisition Corp. / MMCAP International Inc. SPC - FORM SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A AMENDMENT NO.

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 28, 2022 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40744 86-3336784 (State or other jurisdiction of incorporation) (Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSU

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to DTRT Health Acquisition Corp. (E

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 22, 2021 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or other jurisdiction of incorporation) (Com

DTRT Health Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants Commencing October 25, 2021

Exhibit 99.1 DTRT Health Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants Commencing October 25, 2021 NEW YORK?DTRT Health Acquisition Corp. (NASDAQ: DTRTU) (?DTRT? or the ?Company?) announced that, commencing October 25, 2021, holders of the 23,000,000 units sold in the Company?s initial public offering may elect to separately trade the shares of Class A c

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT T

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to DTRT Health Acquisition Corp. (Exact

Saba Capital Management, L.P. - FORM SC 13G

SC 13G 1 formsc13g.htm FORM SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* DTRT Health Acquisition Corp (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 23344T202 (CUSIP Number) September 21, 2021 (Date of Event which Requires Filing of this Statement) Check the a

DTRTU / DTRT Health Acquisition Corp. Unit / CITADEL ADVISORS LLC - DTRT HEALTH ACQUISITION CORP. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* DTRT Health Acquisition Corp. (Name of Issuer) Class A common stock, par value $0.0001 per share (Title of Class of Securities) 23344T202**

JOINT FILING AGREEMENT

EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the Class A common stock of DTRT Health Acquisition Corp., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf of

CANTOR FITZGERALD SECURITIES - SCHEDULE 13G

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 DTRT Health Acquisition Corp. (Name of Issuer) Class A Shares (Title of Class of Securities) 23344T202 (CUSIP Number) September 2, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this schedule is filed: ☐ Rul

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 13, 2021 (September 7, 2021) DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336784 (State or other jurisdiction

DTRT HEALTH ACQUISITION CORP. Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of September 7, 2021 F-3 Notes to Financial Statement F-4

Table of Contents Exhibit 99.1 DTRT HEALTH ACQUISITION CORP. Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of September 7, 2021 F-3 Notes to Financial Statement F-4 Table of Contents Report of Independent Registered Public Accounting Firm To the Stockholders and the Board of Directors of DTRT Health Acquisition Corp. Opinion on the Financial Statement We have audited

DTRT Health Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering

Exhibit 99.1 DTRT Health Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering New York, NY, September 1, 2021 (Business Wire) ? DTRT Health Acquisition Corp. (the ?Company?) today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units will be listed on The NASDAQ Capital Market (?NASDAQ?) and trade under the ticker s

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 8, 2021 (September 1, 2021) DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40774 86-3336748 (State or other jurisdiction o

DTRT Health Acquisition Corp. Announces Closing of $230 Million Initial Public Offering

Exhibit 99.2 DTRT Health Acquisition Corp. Announces Closing of $230 Million Initial Public Offering New York, NY, September 7, 2021 (BUSINESS WIRE) ? DTRT Health Acquisition Corp. (the ?Company?) today announced the closing of its initial public offering of 23,000,000 units at a price of $10.00 per unit, including 3,000,000 units issued pursuant to the exercise by the underwriters of their over-a

Registration Rights Agreement, dated September 1, 2021, by and between the Company and DTRT Health Sponsor LLC.*

Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of September 1, 2021, is made and entered into by and among DTRT Health Acquisition Corp., a Delaware corporation (the ?Company?), and DTRT Health Sponsor LLC, a Delaware limited liability company (the ?Sponsor?, and together with any person or entity who hereafter becomes a party to this Agr

Warrant Agreement, dated September 1, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent.*

Exhibit 4.1 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this ?Agreement?), dated as of September 1, 2021, is by and between DTRT Health Acquisition Corp., a Delaware corporation (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the ?Warrant Agent?, and also referred to herein as the ?Transfer Agent?). WHEREAS, the Company is

Underwriting Agreement, dated September 1, 2021, by and between the Company and Cantor Fitzgerald & Co., as the representative of the underwriters.*

Exhibit 1.1 UNDERWRITING AGREEMENT between DTRT HEALTH ACQUISITION CORP. and CANTOR FITZGERALD & CO. As Representative of the Underwriters Dated: September 1, 2021 DTRT HEALTH ACQUISITION CORP. UNDERWRITING AGREEMENT New York, New York September 1, 2021 Cantor Fitzgerald & Co. 499 Park Avenue New York, New York 10022 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentl

MMCAP International Inc. SPC - FORM SC 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 DTRT Health Acquisition Corp.

Letter Agreement, dated September 1, 2021, by and among the Company, its executive officers, its directors and DTRT Health Sponsor LLC.*

Exhibit 10.1 September 1, 2021 DTRT Health Acquisition Corp. 1415 West 22nd Street, Tower Floor Oak Brook, IL 60523 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into by and among DTRT Health Acquisition Corp., a Delaware corporation (the ?Company

Amended and Restated Certificate of Incorporation.*

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DTRT HEALTH ACQUISITION CORP. September 1, 2021 DTRT Health Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is ?DTRT Health Acquisition Corp.? The original certificate of incorporation was filed with the

Administrative Services Agreement, dated September 1, 2021, by and between the Company and DTRT Health Sponsor LLC.*

Exhibit 10.5 DTRT Health Acquisition Corp. 1415 West 22nd Street, Tower Floor Oak Brook, Illinois 60523 September 1, 2021 DTRT Health Sponsor LLC 1415 West 22nd Street, Tower Floor Oak Brook, Illinois 60523 Re: Administrative Services Agreement Ladies and Gentlemen: This letter agreement (this ?Agreement?) by and among DTRT Health Acquisition Corp. (the ?Company?) and DTRT Health Sponsor LLC (the

Private Placement Warrants Purchase Agreement, dated September 1, 2021, by and between the Company and DTRT Health Sponsor LLC.*

Exhibit 10.4 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of September 1, 2021 (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), is entered into by and between DTRT Health Acquisition Corp., a Delaware corporation (the ?Company?), and DTRT Health Sponsor LLC, a Delaware limited liab

Investment Management Trust Agreement, dated September 1, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee.*

Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of September 1, 2021 by and between DTRT Health Acquisition Corp., a Delaware corporation (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, File No. 333

$200,000,000 DTRT Health Acquisition Corp. 20,000,000 Units

Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-258742 PROSPECTUS $200,000,000 DTRT Health Acquisition Corp. 20,000,000 Units DTRT Health Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 DTRT Health Acquisition Corp. (Exact name of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 DTRT Health Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 85-3336784 (State of incorporation or organization) (I.R.S. Employer Identification No.) 1415 West 22

As filed with the U.S. Securities and Exchange Commission on August 30, 2021.

S-1/A 1 d177895ds1a.htm S-1/A Table of Contents As filed with the U.S. Securities and Exchange Commission on August 30, 2021. Registration No. 333-258742 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaw

Securities Subscription Agreement between the Registrant and DTRT Health Sponsor LLC.*

Exhibit 10.7 DTRT Health Acquisition Corp. 1340 Inverness Lane Schererville, IN 46374 May 12, 2021 DTRT Health Sponsor LLC 1340 Inverness Lane Schererville, IN 46374 RE: Securities Subscription Agreement Ladies and Gentlemen: DTRT Health Acquisition Corp., a Delaware corporation (the ?Company,? ?we? or ?us?), is pleased to accept the offer made by DTRT Health Sponsor LLC, a Delaware limited liabil

Promissory Note issued to DTRT Health Sponsor LLC.*

Exhibit 10.6 THIS PROMISSORY NOTE (?NOTE?) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY

Form of Registration Rights Agreement among the Registrant, DTRT Health Sponsor LLC and the Holders signatory thereto.*

Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of [ ], 2021, is made and entered into by and among DTRT Health Acquisition Corp., a Delaware corporation (the ?Company?), and DTRT Health Sponsor LLC, a Delaware limited liability company (the ?Sponsor?, and together with any person or entity who hereafter becomes a party to this Agreement p

Form of Underwriting Agreement.*

Exhibit 1.1 UNDERWRITING AGREEMENT between DTRT HEALTH ACQUISITION CORP. and CANTOR FITZGERALD & CO. As Representative of the Underwriters Dated: [ ], 2021 DTRT HEALTH ACQUISITION CORP. UNDERWRITING AGREEMENT New York, New York [?], 2021 Cantor Fitzgerald & Co. 499 Park Avenue New York, New York 10022 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The unders

Specimen Unit Certificate.*

Exhibit 4.1 NUMBER U- UNITS SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP DTRT HEALTH ACQUISITION CORP. UNITS CONSISTING OF ONE SHARE OF CLASS A COMMON STOCK AND ONE-HALF OF ONE REDEEMABLE WARRANT TO PURCHASE ONE SHARE OF CLASS A COMMON STOCK THIS CERTIFIES THAT is the owner of Units. Each Unit (?Unit?) consists of one share of Class A common stock, par value $0.0001 per share (?Common Stock?), of DTR

Amended and Restated Certificate of Incorporation.*

Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DTRT HEALTH ACQUISITION CORP. [ ], 2021 DTRT Health Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is ?DTRT Health Acquisition Corp.? The original certificate of incorporation was filed with the Secreta

Form of Indemnity Agreement.*

Exhibit 10.5 INDEMNITY AGREEMENT This INDEMNITY AGREEMENT (this ?Agreement?) is made as of [ ], 2021, by and between DTRT Health Acquisition Corp., a Delaware corporation (the ?Company?), and [ ] (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly held corporations as directors or officers or in other capacities unless they are provided with adeq

As filed with the U.S. Securities and Exchange Commission on August 13, 2021.

Table of Contents As filed with the U.S. Securities and Exchange Commission on August 13, 2021. Registration No. 333-258742 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 6770 86-3336784 (State or

Bylaws (Incorporated by reference to Exhibit 3.3 to the Registrant’s Registration Statement on Form S-1 (File No. 333-258742), filed with the U.S. Securities and Exchange Commission on August 13, 2021).

Exhibit 3.3 BYLAWS OF DTRT HEALTH ACQUISITION CORP. (THE ?CORPORATION?) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporation?s registered agent in De

Form of Audit Committee Charter.*

Exhibit 99.1 DTRT HEALTH ACQUISITION CORP. AUDIT COMMITTEE CHARTER Effective [ ], 2021 I. PURPOSES The Audit Committee (the ?Committee?) is appointed by the Board of Directors (the ?Board?) of DTRT Health Acquisition Corp. (the ?Company?) to assist the Board in its oversight of the accounting and financial reporting processes of the Company and the Company?s compliance with legal and regulatory re

Form of Compensation Committee Charter.*

Exhibit 99.2 DTRT HEALTH ACQUISITION CORP. COMPENSATION COMMITTEE CHARTER Effective [ ], 2021 I. PURPOSES The Compensation Committee (the ?Committee?) is appointed by the Board of Directors (the ?Board?) of DTRT Health Acquisition Corp. (the ?Company?) to: (A) assist the Board in overseeing the Company?s employee compensation policies and practices, including (i) determining and approving the comp

Certificate of Incorporation.*

Exhibti 3.1 CERTIFICATE OF INCORPORATION OF DTRT HEALTH ACQUISITION CORP. April 19, 2021 The undersigned, for the purposes of forming a corporation under the laws of the State of Delaware, does make, file, and record this Certificate of Incorporation (the ?Certificate?), and does hereby certify as follows: ARTICLE I NAME The name of the corporation is DTRT Health Acquisition Corp. (the ?Corporatio

Form of Letter Agreement among the Registrant, DTRT Health Sponsor LLC and each of the executive officers and directors of the Registrant.*

Exhibit 10.1 August [ ], 2021 DTRT Health Acquisition Corp. 1415 West 22nd Street, Tower Floor Oak Brook, IL 60523 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into by and among DTRT Health Acquisition Corp., a Delaware corporation (the ?Company?

Specimen Class A Common Stock Certificate.*

Exhibit 4.2 NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP DTRT HEALTH ACQUISITION CORP. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CLASS A COMMON STOCK THIS CERTIFIES THAT is the owner of fully paid and non-assessable shares of Class A common stock, par value $0.0001 per share (the ?Common Stock?), of DTRT Health Acquisition Corp., a Delaware corporation (the ?Company?), tra

Form of Code of Ethics.*

EX-14 19 d177895dex14.htm EX-14 Exhibit 14 DTRT HEALTH ACQUISITION CORP. CODE OF ETHICS Effective [ ], 2021 I. INTRODUCTION The Board of Directors (the “Board”) of DTRT Health Acquisition Corp. has adopted this code of business conduct and ethics (this “Code”), as amended from time to time by the Board and which is applicable to all of the Company’s directors, officers and employees (to the extent

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant.*

Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of [ ], 2021 by and between DTRT Health Acquisition Corp., a Delaware corporation (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, File No. 333-258742

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant.*

Exhibit 4.4 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this ?Agreement?), dated as of [ ], 2021, is by and between DTRT Health Acquisition Corp., a Delaware corporation (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the ?Warrant Agent?, and also referred to herein as the ?Transfer Agent?). WHEREAS, the Company is engaged

Form of Administrative Services Agreement between the Registrant and DTRT Health Sponsor LLC.*

Exhibit 10.8 DTRT Health Acquisition Corp. 1415 West 22nd Street, Tower Floor Oak Brook, Illinois 60523 August , 2021 DTRT Health Sponsor LLC 1415 West 22nd Street, Tower Floor Oak Brook, Illinois 60523 Re: Administrative Services Agreement Ladies and Gentlemen: This letter agreement (this ?Agreement?) by and among DTRT Health Acquisition Corp. (the ?Company?) and DTRT Health Sponsor LLC (the ?Spo

Specimen Warrant Certificate.*

Exhibit 4.3 Form of Warrant Certificate [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW DTRT HEALTH ACQUISITION CORP. Incorporated Under the Laws of the State of Delaware CUSIP Warrant Certificate This Warrant Certificate certifies that , or registered assigns, is the registered

Form of Private Placement Warrants Purchase Agreement between the Registrant and DTRT Health Sponsor LLC.*

Exhibit 10.4 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of [ ], 2021 (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), is entered into by and between DTRT Health Acquisition Corp., a Delaware corporation (the ?Company?), and DTRT Health Sponsor LLC, a Delaware limited liability co

Consent of Mary Ann Christopher.**

Exhibit 99.5 Consent to be Named as a Director Nominee In connection with the filing by DTRT Health Acquisition Corp. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 under the Securities Act, to being named as a nominee to the board of directors of DTRT

Consent of Jeannee Parker Martin.**

Exhibit 99.3 Consent to be Named as a Director Nominee In connection with the filing by DTRT Health Acquisition Corp. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 under the Securities Act, to being named as a nominee to the board of directors of DTRT

Consent of Dipa Mehta.**

EX-99.4 Exhibit 99.4 Consent to be Named as a Director Nominee In connection with the filing by DTRT Health Acquisition Corp. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 under the Securities Act, to being named as a nominee to the board of directors

Power of Attorney (included on signature page hereto).*

Table of Contents As filed with the U.S. Securities and Exchange Commission on August 11, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DTRT HEALTH ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 6770 86-3336784 (State or other jurisdiction of inc

Consent of Don Klink.**

Exhibit 99.6 Consent to be Named as a Director Nominee In connection with the filing by DTRT Health Acquisition Corp. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 under the Securities Act, to being named as a nominee to the board of directors of DTRT

As confidentially submitted to the U.S. Securities and Exchange Commission on June 9, 2021. This draft registration statement has not been filed, publicly or otherwise, with the U.S. Securities and Exchange Commission and all information contained he

Table of Contents As confidentially submitted to the U.S. Securities and Exchange Commission on June 9, 2021. This draft registration statement has not been filed, publicly or otherwise, with the U.S. Securities and Exchange Commission and all information contained herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FO